Barry S. Ticho
2023
In 2023, Barry S. Ticho earned a total compensation of $1.6M as Chief Medical Officer at Stoke Therapeutics, a 31% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $177,934 |
|---|---|
| Option Awards | $474,186 |
| Salary | $494,259 |
| Stock Awards | $489,272 |
| Other | $12,356 |
| Total | $1,648,007 |
Ticho received $494.3K in salary, accounting for 30% of the total pay in 2023.
Ticho also received $177.9K in non-equity incentive plan, $474.2K in option awards, $489.3K in stock awards and $12.4K in other compensation.
Rankings
In 2023, Barry S. Ticho's compensation ranked 687th out of 2,878 executives tracked by ExecPay. In other words, Ticho earned more than 76.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 687 out of 2,878 | 76th |
Division Manufacturing | 394 out of 1,582 | 75th |
Major group Chemicals And Allied Products | 270 out of 891 | 70th |
Industry group Drugs | 264 out of 854 | 69th |
Industry Pharmaceutical Preparations | 171 out of 614 | 72nd |
Source: SEC filing on April 23, 2024.
Ticho's colleagues
We found two more compensation records of executives who worked with Barry S. Ticho at Stoke Therapeutics in 2023.